Candida Glabrata

Common Name(s)

Candida Glabrata

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Candida Glabrata" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Candida Glabrata" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Candida Glabrata" returned 212 free, full-text research articles on human participants. First 3 results:

Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata isolates.
 

Author(s): Laura Bedin Denardi, Débora Alves Nunes Mario, Érico Silva Loreto, Janio Morais Santurio, Sydney Hartz Alves

Journal:

 

In vitro interaction between tacrolimus (FK506) and four azoles (fluconazole, ketoconazole, itraconazole and voriconazole) against thirty clinical isolates of both fluconazole susceptible and -resistant Candida glabrata were evaluated by the checkerboard microdilution method. Synergistic, ...

Last Updated: 29 Jul 2015

Go To URL
Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 exhibit strong antifungal effects against vulvovaginal candidiasis-causing Candida glabrata isolates.
 

Author(s): S Y Chew, Y K Cheah, H F Seow, D Sandai, L T L Than

Journal: J. Appl. Microbiol.. 2015 May;118(5):1180-90.

 

This study investigates the antagonistic effects of the probiotic strains Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 against vulvovaginal candidiasis (VVC)-causing Candida glabrata.

Last Updated: 8 Apr 2015

Go To URL
[Evaluation of the rapid trehalose test for the identification of the Candida glabrata].
 

Author(s): Chun He, Qin Lin, Zhen-ying Bao, Yan-hong Meng, Xiao-mei Qi, Hong Hua, Zhi-ming Yan

Journal: Beijing Da Xue Xue Bao. 2015 Feb;47(1):186-90.

 

To explore a rapid and cost-effective method for identification of Candida glabrata through the comparison of two different methods, using molecular methods of sequencing as gold standard.

Last Updated: 17 Feb 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Candida Glabrata" returned 6 free, full-text review articles on human participants. First 3 results:

Candida glabrata: new tools and technologies-expanding the toolkit.
 

Author(s): Hsueh-lui Ho, Ken Haynes

Journal: FEMS Yeast Res.. 2015 Sep;15(6):.

 

In recent years, there has been a noticeable rise in fungal infections related to non-albicans Candida species, including Candida glabrata which has both intrinsic resistance to and commonly acquired resistance to azole antifungals. Phylogenetically, C. glabrata is more closely related ...

Last Updated: 18 Aug 2015

Go To URL
Candida glabrata: a deadly companion?
 

Author(s): Monique Bolotin-Fukuhara, Cécile Fairhead

Journal: Yeast. 2014 Aug;31(8):279-88.

 

The yeast Candida glabrata has become a major fungal opportunistic pathogen of humans since the 1980s. Contrary to what its name suggests, it is much closer, phylogenetically, to the model yeast Saccharomyces cerevisiae than to the most prevalent human fungal pathogen, Candida albicans. ...

Last Updated: 18 Aug 2014

Go To URL
Two unlike cousins: Candida albicans and C. glabrata infection strategies.
 

Author(s): Sascha Brunke, Bernhard Hube

Journal: Cell. Microbiol.. 2013 May;15(5):701-8.

 

Candida albicans and C. glabrata are the two most common pathogenic yeasts of humans, yet they are phylogenetically, genetically and phenotypically very different. In this review, we compare and contrast the strategies of C. albicans and C. glabrata to attach to and invade into the ...

Last Updated: 15 Apr 2013

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

There are currently no open clinical trials for this condition.